The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

15 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Novel bivalent inhibitors with sub-nanomolar affinities towards human glyoxalase I.EBI
Chengdu University
Inhibition by active site directed covalent modification of human glyoxalase I.EBI
University Of Maryland
Synthesis and evaluation of alpha-hydroxythiol esters as antitumor agents and glyoxalase I inhibitors.EBI
TBA
Design and evaluation of azaindole-substituted N-hydroxypyridones as glyoxalase I inhibitors.EBI
Chugai Pharmaceutical
S-(N-aryl-N-hydroxycarbamoyl)glutathione derivatives are tight-binding inhibitors of glyoxalase I and slow substrates for glyoxalase II.EBI
University Of Maryland
Discovery of a new type inhibitor of human glyoxalase I by myricetin-based 4-point pharmacophore.EBI
Tokyo University Of Science
Structural investigation into the inhibitory mechanisms of indomethacin and its analogues towards human glyoxalase I.EBI
Sun Yat-Sen University
Identification of curcumin derivatives as human glyoxalase I inhibitors: A combination of biological evaluation, molecular docking, 3D-QSAR and molecular dynamics simulation studies.EBI
Sun Yat-Sen University
Delphinidin, a dietary anthocyanidin in berry fruits, inhibits human glyoxalase I.EBI
Tokyo University Of Science
Structure-activity relationship of human GLO I inhibitory natural flavonoids and their growth inhibitory effects.EBI
Tokyo University Of Science
Reversal of anticancer drug resistance by COTC based on intracellular glutathione and glyoxalase I.EBI
Keio University
Role of hydrophobic interactions in binding S-(N-aryl/alkyl-N-hydroxycarbamoyl)glutathiones to the active site of the antitumor target enzyme glyoxalase I.EBI
University Of Maryland
Synthesis and activity of gamma-(L-gamma-azaglutamyl)-S-(p-bromobenzyl)-L-cysteinylglycine: a metabolically stable inhibitor of glyoxalase I.EBI
University Of Minnesota
Syntheses and kinetic evaluation of hydroxamate-based peptide inhibitors of glyoxalase I.EBI
University Of Waterloo